Matheson Bill Aimed at Protecting Families from Counterfeit Pharmaceuticals Advances05/15/13
Washington D.C.- Congressman Jim Matheson’s bill that would strengthen the safety of America’s prescription drug supply chain advanced out of the Energy and Commerce Committee this morning. The Committee voted to approve H.R. 1919, the Safeguarding America’s Pharmaceuticals Act, a bi-partisan bill introduced with Bob Latta (R-Ohio), aimed at preventing stolen, misbranded, counterfeited or otherwise altered medications from entering our country’s pharmaceutical system.
“This legislation adds no cost to consumers and creates an industry standard to ensure greater patient safety for all Americans,” said Matheson. “It’s critical that when a person fills a prescription they can trust the medication they receive is real and untainted.”
H.R. 1919 establishes a national standard of tracing requirements for manufacturers, wholesale distributors, pharmacies, and repackagers based on changes in ownership. Furthermore, it moves to an electronic, unit-level tracking system that creates a collaborative partnership between the FDA and industry stakeholders.
“Currently, regulations are not efficient and vary by state. This bi-partisan bill streamlines the system by replacing various laws with one uniform standard,” said Matheson. “I look forward to advancing this legislation on the House Floor.”